Immune response to gastrin-17 and survival in gastrointestinal cancers von Oortgiesen, J. M., DiMichele, L. A., Weidman, J. R., Gunto, V. T., Soeder, T., Cato, A., Sutton, L.

Volltext

Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haema... von Kibbelaar, R.E., Oortgiesen, B.E., van der Wal-Oost, A.M., Boslooper, K., Coebergh, J.W., Veeger, N.J.G.M., Joosten, P., Storm, H., van Roon, E.N., Hoogendoorn, M.

Volltext

High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study von Oortgiesen, B. E., Kroes, J. A., Scholtens, P., Hoogland, J., Dannenberg - de Keijzer, P., Siemes, C., Jansman, F. G. A., Kibbelaar, R. E., Veeger, N. J. G. M., Hoogendoorn, M., van Roon, E. N.

Volltext

Effectiveness of a vitamin D regimen in deficient multiple myeloma patients and its effect on peripheral neuropathy von Oortgiesen, Berdien E., Dekens, Marloes, Stapel, Ruud, Alheraky, Abdulrazzaq, Dannenberg, Pauline de Keizer, Siemes, Claire, Jansman, Frank G. A., Kibbelaar, Robby E., Veeger, Nic J. G. M., Hoogendoorn, Mels, van Roon, Eric N.

Volltext

The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study von Oortgiesen, Berdien E, Azad, Roshna, Hemmelder, Marc H, Kibbelaar, Robby E, Veeger, Nic J G M, de Vries, Joost C, van Roon, Eric N, Hoogendoorn, Mels

Volltext

No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control study von Oortgiesen, Berdien E., Driessen, Johanna H.M., Hoogendoorn, Mels, Kibbelaar, Robby E., Veeger, Nic J.G.M., van den Bergh, Joop P.W., Vestergaard, Peter, de Vries, Frank, van Roon, Eric N.

Volltext

Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials... von Gottenberg, Jacques-Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle-Pensec, Valérie, Bowman, Simon J, Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A, Goldenberg, David M, Meno-Tetang, Guy, Kosutic, Gordana, Gordon, Caroline

Volltext

PCR196 Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From... von Magrey, M, Deodhar, A, Mease, PJ, Navarro-Compán, V, Ramiro, S, Rudwaleit, M, de la Loge, C, Fleurinck, C, Taieb, V, Mørup, MF, Oortgiesen, M, Kay, J

Volltext

No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control study von Oortgiesen, Berdien E, Driessen, Johanna H M, Hoogendoorn, Mels, Kibbelaar, Robby E, Veeger, Nic J G M, van den Bergh, Joop P W, Vestergaard, Peter, de Vries, Frank, van Roon, Eric N

Volltext

An open‐label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5‐fluorouracil in patients with untreated, advanced gastric or gastroesophageal can... von Ajani, Jaffer A., Randolph Hecht, J., Ho, Linus, Baker, Jackie, Oortgiesen, Marga, Eduljee, Arnavaz, Michaeli, Dov

Volltext

Efficacy of Epratuzumab, an Anti‐ CD 22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Tria... von Gottenberg, Jacques‐Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle‐Pensec, Valérie, Bowman, Simon J., Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A., Goldenberg, David M., Meno‐Tetang, Guy, Kosutic, Gordana, Gordon, Caroline

Volltext

Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the von Gottenberg, Jacques‐Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle‐Pensec, Valérie, Bowman, Simon J., Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A., Goldenberg, David M., Meno‐Tetang, Guy, Kosutic, Gordana, Gordon, Caroline

Volltext

Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome von Gottenberg, Jacques‐Eric, Dörner, Thomas, Bootsma, Hendrika, Devauchelle‐Pensec, Valérie, Bowman, Simon J., Mariette, Xavier, Bartz, Holger, Oortgiesen, Marga, Shock, Anthony, Koetse, Willem, Galateanu, Catrinel, Bongardt, Sabine, Wegener, William A., Goldenberg, David M., Meno‐Tetang, Guy, Kosutic, Gordana, Gordon, Caroline

Volltext

Particulate Matter Initiates Inflammatory Cytokine Release by Activation of Capsaicin and Acid Receptors in a Human Bronchial Epithelial Cell Line von Veronesi, B., Oortgiesen, M., Carter, J.D., Devlin, R.B.

Volltext

Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line von Veronesi, B., Carter, J.D., Devlin, R.B., Simon, S.A., Oortgiesen, M.

Volltext

Electrostatic Charge Activates Inflammatory Vanilloid (VR1) Receptors von Veronesi, Bellina, Wei, Guangwei, Zeng, Jin-Qi, Oortgiesen, Marga

Volltext

Vanilloid (Capsaicin) Receptors Influence Inflammatory Sensitivity in Response to Particulate Matter von Veronesi, Bellina, Oortgiesen, Marga, Roy, Josee, Carter, Jacqueline D., Simon, Sidney A., Gavett, Steve H.

Volltext

PARTICULATE MATTER INFLAMMATION AND RECEPTOR SENSITIVITY ARE TARGET CELL SPECIFIC von Veronesi, Bellina, Haar, Colin de, Roy, Josee, Oortgiesen, Marga

Volltext

Voltage-gated and Ca(2+)-activated K+ channels in intact human T lymphocytes. Noninvasive measurements of membrane currents, membrane potential, and intracellular calcium von Verheugen, J A, Vijverberg, H P, Oortgiesen, M, Cahalan, M D

Volltext

Le bimékizumab améliore la fonction physique et la qualité de vie liée à l’état de santé chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase I... von Breban, M., Dubreuil, M., Gaffney, K., Gensler, L.S., Kay, J., Navarro-Compán, V., De La Loge, C., Ellis, A.M., Fleurinck, C., Oortgiesen, M., Taieb, V., Deodhar, A.

Volltext